FAST MONEY FEATURES
Get in the post game. Respond to our "Question of the Day" right now.
Grab a pencil because school is in session and the Fast Money traders are teaching class.
Download Fast Money onto your MP3 Player.
Grab this all-in-one application and get recaps of the show sent right to your desktop or blog.
Get your game on with Fast Money gear.
Check out our scrapbook. These "pix" are guaranteed winners.
Sign up and receive a recap email every Friday after the show!
Get advanced information about the next Fast Money.
SAUDI SUNDAY: Saudi Arabia's King Abdullah is calling a gathering of oil producing and consuming nations.
I think they’re going to talk down oil [US@CL.1
Loading...
()
], says Guy Adami.
---------------------------------
FED DECISION: Ben Bernanke speaks Wednesday - will he talk Hawk or Dove?
I’m expecting to hear both hawkish and dovish rhetoric, says Pete Najarian.
---------------------------------
NIKE EARNINGS: The sneaker giant comes out with earnings after the bell on Wednesday.
I think Nike [NKE
Loading...
()
] will beat, says Jeff Macke, but they’re a consumer name in a tough space.
---------------------------------
MONSANTO EARNINGS: Also Wednesday, seed stock Monsanto releases earnings before the bell.
I think Monsanto [MON
Loading...
()
] is a sell the news play, says Quint Tataro. Everyone loves the seeds but not me.
---------------------------------
TECH EARNINGS: Continuing Wednesday's earnings news, BlackBerry maker RIMM and software giant Oracle could make for some major after hours action.
Be patient and wait for a pull back and then you can buy Research In Motion [RIMM
Loading...
()
], says Pete Najarian.
---------------------------------
BED, BATH & BEYOND EARNINGS: Pier 1's disastrous numbers this week don't bode well for Bed, Bath & Beyond which reports -- you guessed it -- Wednesday.
Don’t buy dips in Bed, Bath Beyond [BBBY
Loading...
()
] or the rest of specialty retail, warns Jeff Macke.
---------------------------------
BIOTECH BOOST: The Jeffries Healthcare Conference runs from Tuesday to Thursday and will spotlight a string of biotech names.
I think Isis [ISIS
Loading...
()
], Celgene [CELG
Loading...
()
]and Genzyme [GENZ
Loading...
()
] should deliver the best news, says Pete Najarian.
_____________________________________________________
Got something to to say? Send us an e-mail at and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment but not have it published on our website send those e-mails to .
Trader disclosure: On June 20, 2008, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Adami Owns (AGU), (C), (BTU), (GS), (INTC), (MSFT), (NUE); Macke Owns (INTC), (MSFT), (WMT), (DIS); Najarian Owns (AAPL), (BHI), (CHK), (ENER), (NOK), (TSO), (XLF), (HPQ); Najarian Owns (MER) Puts; Najarian Owns (MYGN) Calls, (SD) Calls; Najarian Owns (HRB) Puts; Quint Tatro Is The Principal Of Tatro Capital; Tatro Owns (C), (DV), (PETS), (STRA), (ESLR), (GLD), (GLW), (GS), (QQQQ), (RIMM), (SDS); Tatro Capital Owns (SLV), (ASTI); Tatro Capital Owns (USO) Puts



